{"version":"1.0","type":"link","title":"Antiemetic drug fosaprepitant exerts anti-tumor effects against NSCLC by targeting FAK to inhibit AKT and JNK/c-Jun pathways.","author_name":"Wang Y 외","author_url":"https://prs-insight.online/author/Wang%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98011","thumbnail_width":1200,"thumbnail_height":630}